Research and Markets: Personalized Medicine – Scientific and Commercial Aspects

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/sdct5t/personalized_medic) has announced the addition of Jain PharmaBiotech's new report "Personalized Medicine - Scientific and Commercial Aspects" to their offering.

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics, pharmacoproteomics, and metabolomics.

Profiles of 264 companies involved in developing technologies for personalized medicines, along with 486 collaborations are included in the part II of the report. Finally the bibliography contains over 650 selected publications cited in the report.The report is supplemented by 65 tables and 18 figures.

Key Topics Covered:

- Basic Aspects

- Molecular Diagnostics in Personalized Medicine

- Pharmacogenetics

- Pharmacogenomics

- Role of Pharmacoproteomics

More:

Research and Markets: Personalized Medicine - Scientific and Commercial Aspects

Related Posts

Comments are closed.